The FDA claims the wearable tech company's BPI offering is 'adulterated' and 'misbranded,' and is being sold without the proper regulatory approvals.

Mattel announced that it has partnered with type 1 diabetes research and advocacy organization Breakthrough T1D to create and ...

In a panel discussion, IT professionals and health system executives discussed the challenges of implementing AI across ...

AI and synthetic-driven research can help clinicians gain a patient's trust, according to Adrienne Boissy, Qualtrics CMO.

Healthcare technology company Aktiia has received FDA 510(k) clearance for its over-the-counter cuffless blood pressure ...

Developing an AI platform internally can be more cost-effective and manageable, said Ryan Sadeghian, chief medical ...

The news comes alongside the U.S. Department of Defense’s announcement of $200 million contracts awarded to xAI, Anthropic, Google and OpenAI for AI implementation.

The funds will be used to increase the development of GAIA-based Alzheimer's disease drugs and widen the pipeline of blockbuster drug candidates.

The company will use the funds to move into the female health space and increase screening and preventive care.

In a panel discussion, experts emphasized that AI must align with clinical workflows, reduce cognitive load, and support – not replace – clinicians.

Mark Newman, founder and CEO of Nomi Health, recommends driving accountability on fully automating payments for primary care ...

The new firm, TandemAI will offer partners an expanded range of methods and workflows for small-molecule and peptide drug ...